Evaxion Biotech Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Evaxion Biotech (EVAX), 60 Degrees Pharmaceuticals, Inc. (SXTP) and Genprex (GNPX)
Evaxion Biotech Analyst Ratings
Evaxion Biotech Analyst Ratings
Buy Rating Affirmed for Evaxion Biotech Amid AI-Driven Vaccine Development Milestones
H.C. Wainwright Initiates Buy Rating on Evaxion Biotech for Its AI Tech Utilization
Evaxion Biotech Analyst Ratings
Lake Street Cuts Price Target on Evaxion Biotech to $7 From $18, Maintains Buy Rating
Lake Street Maintains Buy on Evaxion Biotech, Lowers Price Target to $7
Lake Street Keeps Their Buy Rating on Evaxion Biotech (EVAX)
Evaxion Biotech Analyst Ratings
Oppenheimer Maintains Outperform on Evaxion Biotech, Lowers Price Target to $11
Evaxion Biotech Price Target Announced at $16.00/Share by Oppenheimer
Evaxion Biotech analyst ratings
Oppenheimer Assumes Evaxion Biotech at Outperform, Announces Price Target of $16